Deep Learner: Building AI to Improve Cardiovascular Care
Deep Learner: Building AI to Improve Cardiovascular Care
Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Conversations With Cardiologists: Clinical Perspectives on the Treatment of HFmrEF and HFpEF
Conversations With Cardiologists: Clinical Perspectives on the Treatment of HFmrEF and HFpEF
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
Facing Heart Failure: Trends in the United States
Facing Heart Failure: Trends in the United States
The Importance of Making an Accurate and Timely Heart Failure Diagnosis
The Importance of Making an Accurate and Timely Heart Failure Diagnosis
The Disease Burden and Epidemiology of Heart Failure
The Disease Burden and Epidemiology of Heart Failure
The Interconnectivity of The Cardio-Renal-Metabolic Systems and Associated Comorbidities
The Interconnectivity of The Cardio-Renal-Metabolic Systems and Associated Comorbidities
The Pathophysiology and Pathoetiology of Heart Failure
The Pathophysiology and Pathoetiology of Heart Failure
Guideline Directed Medical Therapy for the Management of Heart Failure
Guideline Directed Medical Therapy for the Management of Heart Failure
Critical Considerations of Residual CV Risk in Patients With T2D & ASCVD
Critical Considerations of Residual CV Risk in Patients With T2D & ASCVD
A Treatment for NYHA Class II-III Obstructive HCM Patients
A Treatment for NYHA Class II-III Obstructive HCM Patients